Company Profile

Verde Environmental Technologies Inc (AKA: Verdeenvirotech)
Profile last edited on: 10/9/2023      CAGE: 6W4N6      UEI: U54UXMWN7VD4

Business Identifier: Drug deactivation products
Year Founded
2011
First Award
2013
Latest Award
2013
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

12900 Whitewater Drive Suite #200
Minnetonka, MN 55343
   (612) 568-1128
   info@verdeenvirotech.com
   www.verdeenvirotech.com
Location: Single
Congr. District: 03
County: Hennepin

Public Profile

Verde Environmental Technologies Inc was founded in order to develop, produce and market a line of patented drug deactivation products sold under the registered trademark names of ContraPatch and MedsAway. Theses products are able to deactivate dangerous drugs by the user/provider/consumer at the point of use, thus rendering the drugs virtually inactive and ready for safe and clean disposal. This product line is able to address the key social issues of prescription drug abuse and environmental contamination. Both products incorporate a proprietary carbon adsorptive technology to “at-source” inactivate residual unwanted active pharmaceutical ingredients in tablets, capsules and patches, making them safe for disposal in an environmentally responsible manner. Activated carbon is considered to be a universal adsorbent, due to its affinity for organic compounds. Pharmaceutical molecules and toxins bind to activated carbon through intermolecular forces and pharmaceuticals that are bound to the activated carbon will no longer be mobile nor physiologically active (e.g. deactivated).  Activated carbon has been frequently administered to patients for the treatment of acute overdose and poisoning in emergency situations and has been found to effectively bind a wide variety of drugs and poisons with a few notable exceptions (e.g. iron, lithium, potassium, and ethanol). The Medsaway Medication Disposal Systems are comprised of pouches containing a deactivating agent. Drugs are placed inside, water is added, and the product is sealed. By chemical adsorption over time, the active pharmaceutical product becomes insoluble and inactive. Laboratory studies of the Medsaway Pouch has shown an average of 98.7% of nine model drugs were found to be deactivated. ContraPatch and MedsAway have market opportunities in direct sales to pharmaceutical companies as well as traditional retail distribution channels. Other areas of focus are at-home healthcare/hospice care, law enforcement and crime prevention programs and other anti-drug abuse and environmental advocacy groups. 

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
15-19

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2013 1 NIH $149,162
Project Title: N-Home Deactivation System for Psychoactive Drugs
2013 1 NIH $149,162
Project Title: Igf::Ot::Igf: In-Home Deactivation System for Psychoactive Drugs. N43da-13-4420.

Key People / Management

  Carter Anderson -- President; Chief Technology Officer

  Clayton Anderson -- Chief Financial Officer

  Andrew Korey -- Chief Executive Officer; Chairman